Eduardo Bravo, Citryll CEO
Dutch biotech nabs €85M to position inflammatory antibody for a pharma buyer
Citryll, a Dutch biotech that has largely flown under the radar for most of its nearly 10-year history, has patched together an €85 million Series …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
